1. Home
  2. CNTX vs BOTJ Comparison

CNTX vs BOTJ Comparison

Compare CNTX & BOTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • BOTJ
  • Stock Information
  • Founded
  • CNTX 2015
  • BOTJ 1998
  • Country
  • CNTX United States
  • BOTJ United States
  • Employees
  • CNTX N/A
  • BOTJ N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • BOTJ Major Banks
  • Sector
  • CNTX Health Care
  • BOTJ Finance
  • Exchange
  • CNTX Nasdaq
  • BOTJ Nasdaq
  • Market Cap
  • CNTX 75.6M
  • BOTJ 62.0M
  • IPO Year
  • CNTX 2021
  • BOTJ N/A
  • Fundamental
  • Price
  • CNTX $0.85
  • BOTJ $15.52
  • Analyst Decision
  • CNTX Strong Buy
  • BOTJ
  • Analyst Count
  • CNTX 5
  • BOTJ 0
  • Target Price
  • CNTX $5.25
  • BOTJ N/A
  • AVG Volume (30 Days)
  • CNTX 121.2K
  • BOTJ 3.1K
  • Earning Date
  • CNTX 11-05-2025
  • BOTJ 10-24-2025
  • Dividend Yield
  • CNTX N/A
  • BOTJ 2.58%
  • EPS Growth
  • CNTX N/A
  • BOTJ N/A
  • EPS
  • CNTX N/A
  • BOTJ 1.57
  • Revenue
  • CNTX N/A
  • BOTJ $46,531,000.00
  • Revenue This Year
  • CNTX N/A
  • BOTJ N/A
  • Revenue Next Year
  • CNTX N/A
  • BOTJ N/A
  • P/E Ratio
  • CNTX N/A
  • BOTJ $9.84
  • Revenue Growth
  • CNTX N/A
  • BOTJ 7.18
  • 52 Week Low
  • CNTX $0.49
  • BOTJ $11.56
  • 52 Week High
  • CNTX $2.59
  • BOTJ $17.05
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 55.84
  • BOTJ 62.46
  • Support Level
  • CNTX $0.81
  • BOTJ $14.29
  • Resistance Level
  • CNTX $0.87
  • BOTJ $15.51
  • Average True Range (ATR)
  • CNTX 0.05
  • BOTJ 0.20
  • MACD
  • CNTX -0.01
  • BOTJ -0.04
  • Stochastic Oscillator
  • CNTX 39.79
  • BOTJ 83.11

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.

Share on Social Networks: